GlassScriptPhysician profile
Jennifer Ellen Hanle
NPI 1649946658
$16,926.21
in general payments reported to CMS, 2019-2025
18 companies · $8,649 in 2025
The $8,649 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.33 · 2022: $346 · 2023: $853 · 2024: $7,004 · 2025: $8,649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,850 · Food and Beverage: $4,719 · Travel and Lodging: $4,142 · Consulting Fee: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,850.00 |
| Food and Beverage | $4,719.34 |
| Travel and Lodging | $4,142.12 |
| Consulting Fee | $794.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $7,506.77 | 2023-2025 | |
| Pfizer INC. | $3,853.02 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,235.54 | 2025 | |
| Celgene Corporation | $1,054.92 | 2022-2025 | Breyanzi |
| Janssen Biotech, INC. | $956.79 | 2023-2025 | Darzalex, Tecvayli, Talvey |
| Adaptive Biotechnologies Corporation | $786.58 | 2022-2025 | Clonoseq |
| Genetix Biotherapeutics INC | $432.24 | 2024 | |
| Janssen Scientific Affairs, LLC | $265.12 | 2024-2025 | Tecvayli, Talvey, Darzalex |
| Gilead Sciences, INC. | $124.18 | 2024 | Trodelvy |
| Karyopharm Therapeutics INC. | $118.09 | 2021-2024 | Xpovio |
| Takeda Pharmaceuticals U.S.A., INC. | $103.07 | 2024 | |
| Johnson & Johnson Health Care Systems INC. | $97.97 | 2025 | Carvykti, Tecvayli, Talvey |
| Kite Pharma, INC. | $94.33 | 2022 | |
| Novartis Pharmaceuticals Corporation | $92.67 | 2022-2024 | |
| Legend Biotech USA INC. | $85.09 | 2025 | Carvykti |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $65.60 | 2023 | Kyprolis |
| Janssen Global Services, LLC | $27.56 | 2025 | |
| Geron Corporation | $26.67 | 2025 | Rytelo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Hanle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.